Additionally, our analysis highlighted the enhanced expression of certain inflammatory markers (e.g., CCL2 and TGFB1/2) during ED with diabetes mellitus, suggesting a pivotal role of local inflammatory responses in the early pathophysiology of diabetes-associated ED. Here, CCL2 is linked to diabetes mellitus.